A diagnosis of cerebral palsy, whether confirmed early in infancy or reached after months of observation, rarely arrives as a surprise to parents who have been watching their child carefully. Something has usually felt different – a preference for one hand, unusual muscle tone, delays in sitting or rolling. What the diagnosis brings is an explanation, a name, and the beginning of a clearer conversation about what support will help.
It also, for many families, brings fear – because cerebral palsy sounds severe, and because the range of what it can mean is enormous. That range is real. CP encompasses children who walk independently with a slight limp and children who require full support for all movement. Understanding where an individual child sits within that spectrum, and what the trajectory of their development looks like with good support, matters far more than the diagnosis label itself.
Healthbooq (healthbooq.com/apps/healthbooq-kids) covers children with additional needs and complex medical conditions.
What Cerebral Palsy Is
Cerebral palsy is an umbrella term for a group of conditions affecting movement and posture that are caused by damage to or abnormal development of the brain during pregnancy, birth, or the first few years of life. The word "cerebral" refers to the brain; "palsy" refers to weakness or problems with body movement. The brain injury itself does not progress – CP is a non-progressive condition – but the way it affects a child's body and function changes as they grow.
Around 1 in 400 children in the UK is affected by cerebral palsy, making it the most common childhood physical disability. Globally, Nadia Badawi and colleagues at the Cerebral Palsy Alliance Research Institute in Sydney have estimated prevalence at around 1.5-2 per 1,000 live births in high-income countries, with rates falling over recent decades as neonatal care has improved.
The underlying brain difference can involve the white matter (as in periventricular leukomalacia, common in premature infants), the cortex, the basal ganglia, the cerebellum, or combinations of these. What the CP affects in terms of muscle tone, movement patterns, and which parts of the body are involved depends on where in the brain the injury occurred.
Types and Classification
CP is classified in several overlapping ways, which can be confusing. The most clinically useful classifications describe the type of motor impairment and the distribution across the body.
By motor type: spastic CP is the most common (around 85% of cases) and involves increased muscle tone – muscles that are stiffer than normal, which can affect the range of movement and cause characteristic movement patterns. Dyskinetic CP involves involuntary movements caused by damage to the basal ganglia; these may be athetoid (slow, writhing), choreoathetoid, or dystonic in character. Ataxic CP involves problems with balance and coordination from cerebellar involvement. Mixed types occur.
By distribution: hemiplegia affects one side of the body (arm and leg on the same side); diplegia predominantly affects the legs; quadriplegia (also called tetraplegia) affects all four limbs. These terms are useful for indicating the pattern of involvement but don't fully capture functional ability.
The Gross Motor Function Classification System (GMFCS), developed by Peter Rosenbaum and colleagues at McMaster University in Canada, has become the standard tool for describing functional ability and predicting trajectory. It uses a five-level scale: Level I children walk without limitations; Level II walk with limitations; Level III walk using a hand-held mobility device; Level IV have limited self-mobility and use powered wheelchairs; Level V are transported in a manual wheelchair. The GMFCS level in early childhood is a reasonable predictor of long-term mobility, with the trajectory largely established by age five.
Causes and Risk Factors
In many cases, the cause of cerebral palsy is not identified. Known causes and risk factors include premature birth (particularly before 32 weeks, where periventricular leukomalacia is common), birth asphyxia (hypoxic-ischaemic encephalopathy), infection during pregnancy (such as cytomegalovirus or rubella), stroke before or shortly after birth, brain bleeds (intraventricular haemorrhage) in premature infants, and brain malformations occurring during fetal development.
Birth asphyxia – oxygen deprivation around the time of delivery – is a significant cause in term babies and has been the focus of substantial intervention work, including therapeutic hypothermia (cooling treatment in the 48 hours after birth), which substantially reduces the risk of CP following hypoxic-ischaemic encephalopathy. Alistair Gunn at the University of Auckland and the TOBY trial in the UK (published in the New England Journal of Medicine, 2008) established the evidence base for cooling as standard neonatal care.
Identifying Cerebral Palsy
CP is often identified before 24 months, though a formal diagnosis may take longer – partly because some features, particularly in mild CP, become clearer only as motor development progresses and deviates from expected milestones. The General Movements Assessment, developed by Heinz Prechtl, identifies abnormal movement patterns in early infancy that are highly predictive of CP; widespread implementation has allowed earlier diagnosis in many neonatal units.
Red flags that prompt assessment include: persistent asymmetry of hand use before 12 months (strong hand dominance before this age is unusual and may suggest hemiplegia), failure to reach motor milestones, abnormal muscle tone (either too stiff or too floppy), persistent primitive reflexes beyond the expected age, and unusual postures.
Diagnosis involves assessment by a paediatrician or paediatric neurologist and usually includes MRI of the brain, which may identify the underlying cause. The absence of an MRI finding does not exclude CP.
Associated Conditions
CP is primarily a motor disorder, but associated conditions are common and affect many children with CP. These include intellectual disability (in around 30-50% of those with CP, though the range is wide), epilepsy (in around 25-35%), speech and language difficulties, feeding and swallowing problems (dysphagia), visual impairment, hearing loss, pain (often undertreated), and emotional and behavioural difficulties. The presence and severity of these associated features varies considerably and is not closely predicted by the GMFCS level.
Management and Support
There is no cure for CP. What early and sustained intervention can do is substantially improve function, prevent secondary complications, and support the child to achieve their potential. The evidence base for early intervention is strongest for physiotherapy and occupational therapy, particularly intensive approaches.
Physiotherapy in CP has shifted considerably over the past two decades away from passive stretching and toward active, task-specific, goal-directed approaches. Constraint-induced movement therapy (CIMT), developed by Edward Taub and colleagues at the University of Alabama, has good evidence for improving upper limb function in hemiplegic CP: restraining the unaffected arm encourages intensive use of the affected one. Intensive bimanual training programmes and the HABIT (Hand-Arm Bimanual Intensive Training) programme developed by Andrew Gordon at Columbia University have also shown good outcomes.
For children with spastic CP, management of spasticity is an important goal. Oral baclofen reduces overall muscle tone; intrathecal baclofen (a pump delivering medication directly into the spinal fluid) is used in more severe cases. Botulinum toxin injections to specific muscles are widely used to reduce local spasticity and improve function, typically combined with physiotherapy. For children with significant fixed contractures or deformity, orthopaedic surgery – including selective dorsal rhizotomy (cutting sensory nerve roots to reduce spasticity) and tendon lengthening procedures – is considered.
Augmentative and alternative communication (AAC) devices and systems are essential for children whose speech is severely affected. Eye-gaze technology has transformed communication possibilities for children with very limited motor function.
Education and Daily Life
Children with CP have a wide range of educational needs depending on the severity of their motor impairment and associated conditions. Many children with mild CP, particularly hemiplegia without intellectual disability, attend mainstream school with minimal support. Others need specialist provision and significant adaptations.
An Education, Health and Care plan (EHC plan) provides the framework for ensuring specialist support is available in school. Physiotherapy, occupational therapy, and speech and language therapy can be incorporated into the school day, which is more effective than treating these as entirely separate from education.
Adults with CP have life expectancies approaching the general population in those without severe associated conditions. The Cerebral Palsy Alliance in Australia has produced comprehensive data on long-term outcomes, and the move toward CP registers (including the UK Cerebral Palsy Register, established at the University of Liverpool) has improved understanding of population-level outcomes.
Scope and the Cerebral Palsy Society are the main UK organisations providing support, information, and advocacy for children with CP and their families.
Key Takeaways
Cerebral palsy (CP) is the most common physical disability in childhood, affecting approximately 1 in 400 children in the UK. It is caused by damage to or differences in the developing brain and results in lifelong difficulties with movement and posture. CP is not progressive – the underlying brain injury does not worsen – though its functional effects change as the child grows. Early intensive intervention, particularly physiotherapy and occupational therapy, substantially improves functional outcomes. Most people with cerebral palsy live into adulthood with good quality of life, and the majority are able to walk.
